메뉴 건너뛰기




Volumn 69, Issue 11, 2012, Pages 922-923

Caution in making inferences from FDA's Adverse Event Reporting System

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FERUMOXYTOL; IRON DEXTRAN;

EID: 84861476325     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120138     Document Type: Letter
Times cited : (16)

References (11)
  • 1
    • 84857592537 scopus 로고    scopus 로고
    • Comparison of rates of reported adverse events associated with i.v. iron products in the United States
    • Bailie GR. Comparison of rates of reported adverse events associated with i.v. iron products in the United States. Am J Health-Syst Pharm. 2012; 69:310-20.
    • (2012) Am J Health-Syst Pharm , vol.69 , pp. 310-320
    • Bailie, G.R.1
  • 2
    • 0002656565 scopus 로고
    • Epidemiology of adverse reaction to non-steroidal anti-inflammatory drugs
    • Weber JC. Epidemiology of adverse reaction to non-steroidal anti-inflammatory drugs. Adv Inflamm Res. 1984; 6:1-7.
    • (1984) Adv Inflamm Res , vol.6 , pp. 1-7
    • Weber, J.C.1
  • 5
    • 77956481295 scopus 로고    scopus 로고
    • Use of parenteral iron products and serious anaphylactic-type reactions
    • Wysowski DK, Swartz L, Borders- Hemphill BV et al. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol. 2010; 85:650-6.
    • (2010) Am J Hematol , vol.85 , pp. 650-656
    • Wysowski, D.K.1    Swartz, L.2    Borders-Hemphill, B.V.3
  • 6
    • 84873075134 scopus 로고    scopus 로고
    • accessed 2012 Apr 12
    • Food and Drug Administration. www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/ Survei llance/AdverseDrugEffects/ default.htm (accessed 2012 Apr 12).
  • 7
    • 84861464954 scopus 로고    scopus 로고
    • A retrospective comparison of adverse reaction rates with the use of three intravenous iron formulations: A single center experience
    • abstract 1537
    • Okam M, Mandell E. A retrospective comparison of adverse reaction rates with the use of three intravenous iron formulations: a single center experience. Blood. 2010; 116:abstract 1537.
    • (2010) Blood , vol.116
    • Okam, M.1    Mandell, E.2
  • 8
    • 79955045302 scopus 로고    scopus 로고
    • Clinical use of intravenous iron: Administration, efficacy and safety
    • Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy and safety. Hematology Am Soc Hematol Educ Program. 2010; 2010:338-47.
    • (2010) Hematology Am Soc Hematol Educ Program , vol.2010 , pp. 338-347
    • Auerbach, M.1    Ballard, H.2
  • 9
    • 34248592639 scopus 로고    scopus 로고
    • Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
    • DOI 10.1080/08860220701278208, PII 778552652
    • Sav T, Tokgoz B, Sapahiogly MH et al. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail. 2007; 29:423-6. (Pubitemid 46752324)
    • (2007) Renal Failure , vol.29 , Issue.4 , pp. 423-426
    • Sav, T.1    Tokgoz, B.2    Sipahioglu, M.H.3    Deveci, M.4    Sari, I.5    Oymak, O.6    Utas, C.7
  • 10
    • 39349083683 scopus 로고    scopus 로고
    • Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations
    • Moniem KA, Bhandari S. Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations. Transfus Altern Transfus Med. 2007; 9:37-42.
    • (2007) Transfus Altern Transfus Med , vol.9 , pp. 37-42
    • Moniem, K.A.1    Bhandari, S.2
  • 11
    • 84873062662 scopus 로고    scopus 로고
    • FIRST: Head-to-head comparison study (Ferumoxytol compared to IRon Sucrose Trial) of the safety and efficacy of ferumoxytol with iron sucrose for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD)
    • Abstract
    • MacDougall IC, McGlaughlin J, Fortin GS et al. FIRST: head-to-head comparison study (Ferumoxytol compared to IRon Sucrose Trial) of the safety and efficacy of ferumoxytol with iron sucrose for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). J Am Soc Nephrol. 22:6B2011. Abstract.
    • J Am Soc Nephrol , vol.22
    • MacDougall, I.C.1    McGlaughlin, J.2    Fortin, G.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.